- 21297 Foothill Blvd, Ste 203 Hayward, CA 94541 (by appointment only)
- (415) 636-9700
- hello@exxceedwellness.com
The first Spravato appointment takes about two hours. Patients self-administer the nasal spray in the clinic under supervision, then remain for approximately 90 minutes of monitoring. Driving afterward is not permitted, so a designated driver
Read MoreThe first TMS appointment is a consultation and mapping session lasting one to one and a half hours. How to prepare, and when treatment begins.
Read MoreExxceed Wellness prepares and submits Spravato prior authorizations for patients at our Hayward, CA clinic. You do not assemble this packet yourself. We are in network with Aetna, Anthem Blue Cross Blue Shield, Cigna, UnitedHealthcare
Read MoreKey facts Updated August 2026 · Reviewed by Nefretiri Abat, PMHNP-BC Spravato coverage is usually approved in phases that follow the label: induction, then continuation and maintenance. Re-authorization turns on documented response, most often measured
Read MoreKey facts Updated August 2026 · Reviewed by Nefretiri Abat, PMHNP-BC Most Spravato denials come down to documentation, not eligibility. The four usual causes: incomplete medication-trial history, diagnosis mismatch, plan policies that still require a
Read MoreKey facts Updated August 2026 · Reviewed by Nefretiri Abat, PMHNP-BC Spravato (esketamine) can only be given in a REMS-certified healthcare setting; it is never taken home. Every dose is followed by at least 2
Read MoreKey facts Updated August 2026 · Reviewed by Nefretiri Abat, PMHNP-BC TMS prior authorization is decided on the chart: diagnosis, measured symptom severity, and a complete antidepressant trial history. Each medication trial must be documented
Read MoreKey facts Updated August 2026 · Reviewed by Nefretiri Abat, PMHNP-BC A standard insurance-authorized TMS course is 36 sessions: 5 per week for about 6 weeks, then a 6-session taper. Insurers authorize the course as
Read MoreDepression can return after a successful course of TMS, and most insurance plans anticipate that. Coverage for a second acute course, usually called re-treatment, is common when you responded the first time, symptoms have returned,
Read MoreTMS is FDA-cleared as an adjunct treatment for obsessive-compulsive disorder, so coverage for OCD is legitimate rather than experimental. It is, however, narrower and less uniformly covered than TMS for major depression. Plans generally require
Read More
